Eight elderly workers at a German care home were mistakenly injected with five times the recommended dose of the Pfizer/Biontech vaccine, local authorities said Monday.
The incident happened on Sunday in the northeastern city of Stralsund in the Vorpommern-Ruegen district. District chief Stefan Kerth said in a statement that he regretted the mishap.
"I deeply regret the incident. This single event is the result of an individual mistake. I hope that all those affected will not develop serious side-effects," he said.
Those injected with the drug were aged between 66 and 82. They were sent home as soon as the mistake came to light. Four developed flu-like symptoms and were hospitalized for observation.
The district authority pointed out that the vaccine's German developer, Biontech, had used higher doses during the first phase of trials and observed no lasting side-effects in the volunteers.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
)